miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast CancerElisabetta Crippa(Fondazione IRCCS Istituto Nazionale dei Tumori), Marco A. Pierotti(Fondazione IRCCS Istituto Nazionale dei Tumori)PLoS ONEJanuary 27, 201410.1371/journal.pone.0087039Cited by 66SaveCiteExport RISWatch citationsRelated PapersmiR-342 overexpression results in a synthetic lethal phenotype in <i>BRCA1</i>-mutant HCC1937 breast cancer cells|Oncotarget|2016|23